Summary: CHAOJU EYE CARE (02219) reported Revenue of 1.36B(-3.21%); Operating profit of 268.33M(-1.85%); Net profit attributable to owners of 183.44M(-5.96%).
ReportedYoY
Prior YearYoY
RevenueDown YoY
1.36B3.21%
1.41B2.62%
Operating profitDown YoY
268.33M1.85%
273.38M12.23%
Net profit attributable to ownersDown YoY
183.44M5.96%
195.08M14.78%
Revenue
ReportedUnit: CNY
Operating profit
ReportedUnit: CNY
Net profit attributable to owners
ReportedUnit: CNY
FY2026 Interim Report
Reporting period: 2026.01.01-2026.06.30
Summary: CHAOJU EYE CARE (02219) reported Revenue of 710.69M(+1.78%); Net profit attributable to owners of 94.72M(-16.65%).
ReportedYoY
Prior YearYoY
RevenueUp YoY
710.69M1.78%
698.26M--
Net profit attributable to ownersDown YoY
94.72M16.65%
113.64M--
Revenue
ReportedUnit: CNY
Net profit attributable to owners
ReportedUnit: CNY
Gross marginYoY
Unit: CNY
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
Gross marginYoY
Unit: CNY
H1 2025
H1 2026
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
RevenueYoY
Unit: CNY
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Revenue
(YoY)
Cost
(YoY)
Expenses
(YoY)
Interest
(YoY)
Income Tax
(YoY)
Profit
(YoY)
RevenueYoY
Unit: CNY
H1 2025
H1 2026
Revenue
(YoY)
Cost
(YoY)
Expenses
(YoY)
Interest
(YoY)
Income Tax
(YoY)
Profit
(YoY)
Cash and cash equivalentsYoY
Unit: CNY
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Cash and cash equivalentsYoY
Unit: CNY
H1 2025
H1 2026
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Net cash from operating activitiesYoY
Unit: CNY
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Net cash from operating activitiesYoY
Unit: CNY
H1 2025
H1 2026
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Dividends
Dividend per share (last 12 months)
0.24 HKD
Dividend yield
+10.16%
Payments (last 12 months)
1
Sum of per-share cash dividends already ex-dividend, as of 2026-05-14; amounts in different currencies are not converted.
Buybacks
Total repurchased
3.53M HKD
Shares repurchased
1.45M
Buyback days
14
Cumulative since 2026-09-16 (from HKEXnews next-day disclosure returns; earlier records are not included).
Dividend Details
Dividend Details
Ex-date
Payment Date
Record Date
HKD0.2423Final每股派港币0.2423元
2026-05-14
2026-06-03
2026/05/18-2026/05/20
HKD0.1193Final每股派港币0.1193元
2025-06-10
2025-06-27
2025/06/12-2025/06/16
HKD0.1307Interim每股派港币0.1307元
2024-09-11
2024-09-25
2024/09/13-2024/09/17
HKD0.0767Special每股派港币0.0767元
2024-06-12
2024-06-28
2024/06/14-2024/06/18
HKD0.2208Final每股派港币0.2208元
2024-06-12
2024-06-28
2024/06/14-2024/06/18
HKD0.1738Final每股派港币0.1738元
2023-06-12
2023-06-28
2023/06/14-2023/06/16
HKD0.1043Final每股派港币0.1043元
2022-06-10
2022-06-28
2022/06/14-2022/06/16
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows CHAOJU EYE CARE (02219) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.